Welcome to the 2022 CPRIT Annual Report
Texas leads the country in its unprecedented commitment to preventing cancer and researching and developing new technologies to detect, treat, and cure cancer. Created by the Texas Legislature and approved by two statewide votes in 2007 and 2019, the Cancer Prevention & Research Institute of Texas (CPRIT) is now the largest state funder of cancer research in the nation, and the second largest in the world. And our dedication to the fight against cancer is uniquely Texan.
This 2022 Annual Report highlights CPRIT’s mission and how we support those working every day to end the burden of cancer for all Texans.
Please use the navigation bar at the top to browse the report. Here are a few quick links below to help you get started.
- CPRIT Milestones Agency program milestones achieved in 2022
- Interactive Mission Map See how CPRIT is accomplishing its mission all across Texas
- FY 2022 Program Priorities Learn about priorities that guide CPRIT’s three programs
- Published Research Findings Read concise summaries of CPRIT-funded research
- CPRIT Financial Information A closer look at FY2022 agency revenue and expenditures
Wayne R. RobertsChief Executive Officer
Created with overwhelming bipartisan support from the Texas Legislature and adopted by the people of Texas in two statewide votes, CPRIT is entrusted with $6 billion to support groundbreaking research into preventing, diagnosing, treating, and surviving cancer.
Because of this unparalleled commitment by Texans to the fight against cancer, CPRIT is the second largest public funder of cancer research in the world, second only to the National Cancer Institute.
I am proud to introduce the 2022 CPRIT Annual Report and provide a snapshot of our thirteenth year as the state’s cancer-fighting agency. A year of landmarks, in 2022 CPRIT surpassed $2 billion in grants for groundbreaking academic research, provided more than 8 million prevention services statewide and cumulatively invested in more than 50 Texas companies developing breakthroughs in cancer-fighting drugs and treatments.
CPRIT’s recruitment program is one of the most visible means by which we support Texas research institutions and contribute to the state’s life science infrastructure.
CPRIT has enabled Texas academic institutions to recruit 288 of the best and brightest researchers from not only the United States but around the world.
To illustrate the global reach of the CPRIT Scholar program, this year the Texas A&M Engineering Experiment Station received a $6 million grant to recruit Dr. Vanderlei Bagnato from the University of Sao Paulo, Brazil, making him the first CPRIT Scholar from South America.
CPRIT continues to expand the number of Texas institutions receiving academic research and prevention awards. This year, the University of Houston Downtown received its first CPRIT Prevention award to increase the use of life-saving HPV vaccination services among medically underserved young adults in seven Texas counties. Located in the heart of downtown Houston, University of Houston Downtown has among the most diverse student population in America.
Many of our Product Development Research grantees have also seen notable advances this year, including important FDA and European Commission drug designations for products from Aravive and Dialectic Therapeutics.
You can read more about the development of Dialectic’s DT2216 for the treatment of T-cell lymphoma here.
As CPRIT enters its second decade, we remain true to our three-part mission to invest in the state’s research prowess, create and expand life science infrastructure across Texas, and expedite innovation in cancer research and prevention strategies.
In this report, I’m proud to introduce the Mission Map, a new, interactive tool depicting how CPRIT is achieving our mission in every corner of the state. Grant projects featured on the Mission Map show recent or ongoing CPRIT-funded projects and demonstrate the effect CPRIT is having in the fight against cancer.
You may visit the Mission Map here.
The many articles and highlights in this report illustrate not only the advancements made by our grantees across Texas, but also serve to remind us how important CPRIT is in the fight against cancer.
CPRIT acts as a hub to connect universities, researchers, physicians, companies, hospitals, and clinics across Texas, forming a critical infrastructure of distinguished cancer-fighting talent. This connectivity and the ability to judiciously use resources to create high quality jobs, support critical lab assets, and drive innovation in cancer research provides a real-world benefit by reducing the burden of cancer for all Texans.
While the physical and emotional weight of cancer is all too familiar to most Texans, many may not realize that cancer takes an enormous toll on the Texas economy as well. In this report, we provide a look at the economic cost of cancer and how CPRIT and its grantees provide a financial return on the state’s investment in cancer research and prevention.
CPRIT is grateful for those constantly striving to reduce the burden of cancer across Texas. Their dedication and support continue to inspire us. On behalf of the CPRIT Oversight Committee and CPRIT staff, we appreciate the opportunity to keep our promise to make Texas a worldwide leader in the fight against cancer.
Through CPRIT and in thousands of personal ways, Texans Conquer Cancer.
Sincerely,
Wayne R. Roberts
Chief Executive Officer